Ende Eric J

CIK 00014943865 companiesDUBLIN 2, L2

SEC Profile

Transactions

Companies

Filings

CIK

0001494386

Recent Transactions

50 trades

Disposition to Issuer
AVADEL PHARMACEUTICALS PLC$AVDL
Stock Option (Right to Buy)
2026-02-12−11,000→ 0 total
Disposition to Issuer
AVADEL PHARMACEUTICALS PLC$AVDL
Ordinary Shares
2026-02-12$21.00/sh−219,905→ 0 total
Disposition to Issuer
AVADEL PHARMACEUTICALS PLC$AVDL
Stock Option (Right to Buy)
2026-02-12−8,057→ 0 total
Disposition to Issuer
AVADEL PHARMACEUTICALS PLC$AVDL
Stock Option (Right to Buy)
2026-02-12−60,000→ 0 total
Disposition to Issuer
AVADEL PHARMACEUTICALS PLC$AVDL
Stock Option (Right to Buy)
2026-02-12−42,000→ 0 total
Disposition to Issuer
AVADEL PHARMACEUTICALS PLC$AVDL
Stock Option (Right to Buy)
2026-02-12−42,000→ 0 total
Disposition to Issuer
AVADEL PHARMACEUTICALS PLC$AVDL
Stock Option (Right to Buy)
2026-02-12−42,000→ 0 total
Disposition to Issuer
AVADEL PHARMACEUTICALS PLC$AVDL
Stock Option (Right to Buy)
2026-02-12−33,000→ 0 total
Disposition to Issuer
AVADEL PHARMACEUTICALS PLC$AVDL
Stock Option (Right to Buy)
2026-02-12−11,000→ 0 total
Award
AVADEL PHARMACEUTICALS PLC$AVDL
Ordinary Shares
2025-07-29+11,000→ 219,900 total
Award
AVADEL PHARMACEUTICALS PLC$AVDL
Stock Option (Right to Buy)
2025-07-29+11,000→ 11,000 total
Purchase
AVADEL PHARMACEUTICALS PLC$AVDL
Ordinary Shares
2025-01-13$7.84/sh+30,000→ 208,900 total
Award
AVADEL PHARMACEUTICALS PLC$AVDL
Stock Option (Right to Buy)
2024-07-30+11,000→ 11,000 total
Award
AVADEL PHARMACEUTICALS PLC$AVDL
Ordinary Shares
2024-07-30+11,000→ 178,900 total
Award
Matinas BioPharma Holdings, Inc.$MTNB
Stock option (right to buy)
2023-11-01+437,244→ 437,244 total
Award
AVADEL PHARMACEUTICALS PLC$AVDL
Stock Option (Right to Buy)
2023-08-01+33,000→ 33,000 total
Purchase
AVADEL PHARMACEUTICALS PLC$AVDL
ADSs
2023-05-18$13.93/sh+13,000→ 167,900 total
Purchase
AVADEL PHARMACEUTICALS PLC$AVDL
ADSs
2022-11-22$7.80/sh+20,000→ 154,900 total
Award
Matinas BioPharma Holdings, Inc.$MTNB
Stock option (right to buy)
2022-11-14+142,657→ 142,657 total
Award
NeuBase Therapeutics, Inc.
Stock option (right to buy)
2022-09-09+37,600→ 37,600 total
Award
AVADEL PHARMACEUTICALS PLC$AVDL
Stock Option (Right to Buy)
2022-08-03+42,000→ 42,000 total
Purchase
AVADEL PHARMACEUTICALS PLC$AVDL
ADSs
2022-06-01$2.27/sh+20,000→ 134,900 total
Purchase
AVADEL PHARMACEUTICALS PLC$AVDL
ADSs
2022-05-31$2.16/sh+15,000→ 114,900 total
Purchase
AVADEL PHARMACEUTICALS PLC$AVDL
ADSs
2022-05-27$2.45/sh+15,000→ 99,900 total
Award
NeuBase Therapeutics, Inc.
Stock option (right to buy)
2022-01-01+165,803→ 165,803 total
Award
Matinas BioPharma Holdings, Inc.$MTNB
Stock option (right to buy)
2021-11-01+90,882→ 90,882 total
Award
AVADEL PHARMACEUTICALS PLC$AVDL
Stock Option (Right to Buy)
2021-08-03+42,000→ 42,000 total
Conversion
Matinas BioPharma Holdings, Inc.$MTNB
Common Stock, par value $0.0001 per share
2021-06-19+24,000→ 144,092 total
Other
Matinas BioPharma Holdings, Inc.$MTNB
Common Stock, par value $0.0001 per share
2021-06-19+4,800→ 120,092 total
Conversion
Matinas BioPharma Holdings, Inc.$MTNB
Series B Preferred Stock
2021-06-19−12→ 0 total
Award
Matinas BioPharma Holdings, Inc.$MTNB
Stock option (right to buy)
2020-11-02+122,605→ 122,605 total
Purchase
AVADEL PHARMACEUTICALS PLC$AVDL
ADSs
2020-09-17$5.79/sh+17,000→ 84,900 total
Purchase
AVADEL PHARMACEUTICALS PLC$AVDL
ADSs
2020-08-13$7.74/sh+1,200→ 64,100 total
Purchase
AVADEL PHARMACEUTICALS PLC$AVDL
ADSs
2020-08-13$7.80/sh+3,800→ 67,900 total
Purchase
AVADEL PHARMACEUTICALS PLC$AVDL
ADSs
2020-08-12$7.76/sh+15,000→ 62,900 total
Award
AVADEL PHARMACEUTICALS PLC$AVDL
Stock Option (Right to Buy)
2020-08-07+42,000→ 42,000 total
Other
Matinas BioPharma Holdings, Inc.$MTNB
Common Stock, par value $0.0001 per share
2020-06-23+3,600→ 115,292 total
Disposition to Issuer
PROGENICS PHARMACEUTICALS INC
Stock Option (Right to Buy)
2020-06-19−16,393→ 0 total
Disposition to Issuer
PROGENICS PHARMACEUTICALS INC
Stock Option (Right to Buy)
2020-06-19−40,000→ 0 total
Award
PROGENICS PHARMACEUTICALS INC
Non-Qualified Stock Option (Right to Buy)
2019-12-13+16,393→ 16,393 total
Award
PROGENICS PHARMACEUTICALS INC
Non-Qualified Stock Option (Right to Buy)
2019-12-13+40,000→ 40,000 total
Purchase
AVADEL PHARMACEUTICALS PLC$AVDL
ADSs
2019-12-04$5.97/sh+10,000→ 47,900 total
Purchase
AVADEL PHARMACEUTICALS PLC$AVDL
ADSs
2019-11-15$4.98/sh+10,000→ 37,900 total
Award
Matinas BioPharma Holdings, Inc.$MTNB
Stock option (right to buy)
2019-11-01+107,416→ 107,416 total
Purchase
Matinas BioPharma Holdings, Inc.$MTNB
Common Stock, par value $0.0001 per share
2019-08-20$0.66/sh+20,000→ 109,292 total
Purchase
Matinas BioPharma Holdings, Inc.$MTNB
Common Stock, par value $0.0001 per share
2019-08-19$0.68/sh+20,000→ 89,292 total
Award
AVADEL PHARMACEUTICALS PLC$AVDL
Stock Option (right to buy)
2019-08-07+60,000→ 60,000 total
Other
Matinas BioPharma Holdings, Inc.$MTNB
Common Stock, par value $0.0001 per share
2019-06-21+2,400→ 111,692 total
Award
AVADEL PHARMACEUTICALS PLC$AVDL
Stock Option (right to buy)
2019-05-22+8,057→ 8,057 total
Award
AVADEL PHARMACEUTICALS PLC$AVDL
ADSs
2019-01-31+27,900→ 27,900 total

Companies

Recent Filings

Address

C/O AVADEL PHARMACEUTICALS PLC 10 EARLSFORT TERRACE

DUBLIN 2, L2, D02 T380

View on SEC.gov